Home NDC 53225-1111-01 NDC 53225-1111-01 - BONDLIDO This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
Product NDC 53225-1111
Requested NDC 53225-1111-01
Package NDCs from labels 53225-1111-1, 53225-1111-3, 53225-1111-01
Manufacturer Terrain Pharmaceuticals, Inc.
Effective date 2026-09-30
Current FDA listing Not matched in FDA.report NDC product tables
openFDA label cross-check# OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
Matched openFDA labels page 22 of 50 · 996 matching rows.
Brand, Generic, Manufacturer table Brand Generic Manufacturer SPL set ID Effective date Available safety fields Join Lidocaine Pain Relief Gel Patch LIDOCAINE PAIN RELIEF Dynarex 960e4240-cd09-2560-e053-2a95a90a7bcf 2026-01-28 Warnings Exact identifier unii: 98PI200987 Lidocaine LIDOCAINE Fougera Pharmaceuticals, LLC 88ca9cba-0c4a-482f-b502-ceefdb1bfbcd 2026-01-28 Warnings, Adverse reactions Exact identifier unii: 98PI200987 Lidocan LIDOCAINE 5% PURETEK CORPORATION fd8e4856-3785-4850-e053-6294a90a95b6 2026-01-27 Warnings, Adverse reactions Exact identifier unii: 98PI200987 Lidocaine Pain Relief LIDOCAINE Trifecta Pharmaceuticals USA, LLC. 493c09d0-16d7-7413-e063-6394a90aa052 2026-01-26 Warnings Exact identifier unii: 98PI200987 CVS 9083 Maximum Strength Lidocaine 4 Pain Relief Patch 1ct Large LIDOCAINE CVS PHARMACY, INC 4914965f-1164-e20e-e063-6294a90ac221 2026-01-23 Warnings Exact identifier unii: 98PI200987 Black Cobra Tattoo NumbingSpray 4% Lidocaine LIDOCAINE Foshan Sugar Max Cosmetics CO.,Ltd 3605fcbf-63c8-87b5-e063-6294a90a9c3e 2026-01-19 Warnings Exact identifier unii: 98PI200987 Black Cobra Tattoo Numbing Cream 4% Lidocaine LIDOCAINE Foshan Sugar Max Cosmetics CO.,Ltd 3605961a-d596-9c4a-e063-6394a90a99dc 2026-01-19 Warnings Exact identifier unii: 98PI200987 DYNAMO DELAY SAMPLE BOTTLE LIDOCAINE Momentum Management LLC 05370186-1b82-4d0f-9382-b153252c0221 2026-01-19 Warnings Exact identifier unii: 98PI200987 Aspercreme with Lidocaine LIDOCAINE Chattem, Inc. 7ad8efa9-7031-4cd0-be1d-6dee63091fd1 2026-01-19 Warnings Exact identifier unii: 98PI200987 TOPCARE PAIN RELIEF PATCHES LIDOCAINE TOPCO ASSOCIATES, LLC fa2f7768-e779-4409-aad3-6c33ce2e6b36 2026-01-18 Warnings Exact identifier unii: 98PI200987 Aspercreme with Lidocaine XL LIDOCAINE Chattem, Inc. b0859b10-539e-4905-ab52-af78b778d6a4 2026-01-15 Warnings Exact identifier unii: 98PI200987 Pain Relieving Patch LIDOCAINE FlexiGo Inc. 4868af2a-c4be-9c68-e063-6394a90a565b 2026-01-15 Warnings Exact identifier unii: 98PI200987 Hemorrhoid and Fissure GLYCERIN 6%,LIDOCAINE 4%,ECTOIN 0.12% FlexiGo Inc 48697377-61c0-1b0a-e063-6294a90a3293 2026-01-15 Warnings Exact identifier unii: 98PI200987 Careland Lidocaine 4 Pain Relieving Gel-Patches LIDOCAINE Planet (Anhui) Pharmaceutical Co., Ltd. a6ca8382-7ce5-4df9-912e-8a0ac0423116 2026-01-15 Warnings Exact identifier unii: 98PI200987 Icy Hot Lidocaine Dry LIDOCAINE, MENTHOL Chattem, Inc. d500a74e-ab93-4919-8665-a89e9d4cad28 2026-01-15 Warnings Exact identifier unii: 98PI200987 LIDOCORE (single unit patch) LIDOCAINE 4% Ion Pharma, LLC 161f5745-fec1-4ca3-be42-512f6d3e7fee 2026-01-14 Warnings Exact identifier unii: 98PI200987 LIDOCORE LIDOCAINE 4% Ion Pharma, LLC 12dec398-1082-45ad-a517-8f12873b1909 2026-01-14 Warnings Exact identifier unii: 98PI200987 Lidocaine LIDOCAINE 4% AvKARE 70aace2f-47b4-e961-e053-2991aa0a6367 2026-01-14 Warnings Exact identifier unii: 98PI200987 Lidocaine LIDOCAINE AvKARE 0a4cc4f8-9c5d-d03f-e063-6394a90a1b2e 2026-01-14 Warnings, Adverse reactions Exact identifier unii: 98PI200987 Icy Hot with Lidocaine No-Mess MENTHOL AND LIDOCAINE Chattem, Inc. a2803c07-bf39-4028-9262-5082da25b46e 2026-01-14 Warnings Exact identifier unii: 98PI200987
Reported adverse events (FAERS/openFDA)# Adverse event summaries are temporarily unavailable. Other product information remains available.